167 related articles for article (PubMed ID: 12974502)
1. Intestinal aspects of cholesterol gallstone formation.
van Erpecum KJ; van Berge Henegouwen GP
Dig Liver Dis; 2003 Jul; 35 Suppl 3():S8-11. PubMed ID: 12974502
[TBL] [Abstract][Full Text] [Related]
2. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
Wang HH; Portincasa P; Wang DQ
Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
[TBL] [Abstract][Full Text] [Related]
3. Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients.
Stolk MF; Van Erpecum KJ; Peeters TL; Samsom M; Smout AJ; Akkermans LM; Vanberge-Henegouwen GP
Dig Dis Sci; 2001 Jun; 46(6):1328-34. PubMed ID: 11414312
[TBL] [Abstract][Full Text] [Related]
4. Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.
Wang HH; Liu M; Portincasa P; Tso P; Wang DQ
Neurogastroenterol Motil; 2016 Mar; 28(3):364-75. PubMed ID: 26604077
[TBL] [Abstract][Full Text] [Related]
5. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
6. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for
Wang HH; Portincasa P; Liu M; Tso P; Wang DQ
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260332
[TBL] [Abstract][Full Text] [Related]
7. Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans.
Portincasa P; Peeters TL; van Berge-Henegouwen GP; van Solinge WW; Palasciano G; van Erpecum KJ
Neurogastroenterol Motil; 2000 Oct; 12(5):421-30. PubMed ID: 11012942
[TBL] [Abstract][Full Text] [Related]
8. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
9. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention.
vanBerge-Henegouwen GP; Venneman NG; van Erpecum KJ; Portincasa P
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):185-91. PubMed ID: 16089351
[TBL] [Abstract][Full Text] [Related]
10. Measurement of gallbladder motor functions: an overview.
Jazrawi RP
Dig Liver Dis; 2003 Jul; 35 Suppl 3():S51-5. PubMed ID: 12974511
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of motilin on interdigestive motility of the human gastric antrum, pylorus, small intestine and gallbladder.
Luiking YC; Akkermans LM; van der Reijden AC; Peeters TL; van Berge-Henegouwen GP
Neurogastroenterol Motil; 2003 Apr; 15(2):103-11. PubMed ID: 12680909
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of gallstones.
Venneman NG; van Erpecum KJ
Gastroenterol Clin North Am; 2010 Jun; 39(2):171-83, vii. PubMed ID: 20478481
[TBL] [Abstract][Full Text] [Related]
13. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis.
Venneman NG; Renooij W; Rehfeld JF; VanBerge-Henegouwen GP; Go PM; Broeders IA; van Erpecum KJ
Hepatology; 2005 Apr; 41(4):738-46. PubMed ID: 15793851
[TBL] [Abstract][Full Text] [Related]
14. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.
Portincasa P; Moschetta A; Berardino M; Di-Ciaula A; Vacca M; Baldassarre G; Pietrapertosa A; Cammarota R; Tannoia N; Palasciano G
World J Gastroenterol; 2004 Aug; 10(16):2383-90. PubMed ID: 15285024
[TBL] [Abstract][Full Text] [Related]
15. Coordinate regulation of gallbladder motor function in the gut-liver axis.
Portincasa P; Di Ciaula A; Wang HH; Palasciano G; van Erpecum KJ; Moschetta A; Wang DQ
Hepatology; 2008 Jun; 47(6):2112-26. PubMed ID: 18506897
[TBL] [Abstract][Full Text] [Related]
16. Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.
Wang HH; Liu M; Li X; Portincasa P; Wang DQ
Eur J Clin Invest; 2017 Apr; 47(4):328-333. PubMed ID: 28186337
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal defects in gallstone and cholecystectomized patients.
Di Ciaula A; Molina-Molina E; Bonfrate L; Wang DQ; Dumitrascu DL; Portincasa P
Eur J Clin Invest; 2019 Mar; 49(3):e13066. PubMed ID: 30592298
[TBL] [Abstract][Full Text] [Related]
18. Gallstones: an intestinal disease?
Van Erpecum KJ; Van Berge-Henegouwen GP
Gut; 1999 Mar; 44(3):435-8. PubMed ID: 10026334
[TBL] [Abstract][Full Text] [Related]
19. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
[TBL] [Abstract][Full Text] [Related]
20. Review: pathogenesis of gallstones.
Dowling RH
Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
